X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6804) 6804
Publication (561) 561
Newsletter (253) 253
Book Review (40) 40
Book Chapter (33) 33
Newspaper Article (16) 16
Magazine Article (7) 7
Book / eBook (6) 6
Dissertation (6) 6
Conference Proceeding (3) 3
Data Set (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3965) 3965
male (3320) 3320
index medicus (3071) 3071
animals (2792) 2792
female (2670) 2670
amides - administration & dosage (2346) 2346
amides (1488) 1488
middle aged (1480) 1480
adult (1463) 1463
anesthetics, local - administration & dosage (1451) 1451
rats (1376) 1376
pharmacology & pharmacy (1115) 1115
amides - pharmacology (1070) 1070
aged (1035) 1035
anesthesiology (1020) 1020
mice (976) 976
ropivacaine (909) 909
amides - therapeutic use (830) 830
double-blind method (777) 777
dose-response relationship, drug (703) 703
treatment outcome (670) 670
prospective studies (663) 663
amides - adverse effects (617) 617
time factors (615) 615
surgery (597) 597
bupivacaine (596) 596
research (579) 579
pain (567) 567
pain measurement (567) 567
nerve block - methods (498) 498
neurosciences (497) 497
analysis (494) 494
pain, postoperative - prevention & control (486) 486
analgesia (465) 465
acid amide hydrolase (456) 456
pain, postoperative - drug therapy (455) 455
anesthesia (445) 445
administration, oral (436) 436
rats, sprague-dawley (419) 419
amides - chemistry (413) 413
care and treatment (396) 396
chemistry, medicinal (381) 381
health aspects (355) 355
biochemistry & molecular biology (351) 351
rats, wistar (342) 342
endocrinology & metabolism (341) 341
adolescent (340) 340
medicine (339) 339
pregnancy (339) 339
analgesics, opioid - administration & dosage (338) 338
disease models, animal (337) 337
drug therapy, combination (334) 334
anesthetics, local - adverse effects (329) 329
amides - pharmacokinetics (325) 325
blood pressure - drug effects (321) 321
bupivacaine - administration & dosage (314) 314
endocannabinoids (309) 309
efficacy (306) 306
research article (301) 301
hypertension (300) 300
physiological aspects (296) 296
aged, 80 and over (290) 290
structure-activity relationship (289) 289
anandamide (283) 283
article (279) 279
anesthetics, local - therapeutic use (275) 275
abridged index medicus (270) 270
multidisciplinary sciences (268) 268
enzyme inhibitors - pharmacology (265) 265
antihypertensive agents - administration & dosage (264) 264
enzymes (263) 263
rodents (262) 262
pharmacology (261) 261
renin - antagonists & inhibitors (261) 261
young adult (260) 260
pyridines - pharmacology (257) 257
medicine & public health (249) 249
lipids (245) 245
nerve block (245) 245
antihypertensive agents - therapeutic use (244) 244
brain (244) 244
cloprostenol - analogs & derivatives (244) 244
mice, inbred c57bl (241) 241
amide (240) 240
bimatoprost (240) 240
pharmacokinetics (239) 239
fatty acids (238) 238
hypertension - drug therapy (234) 234
drugs (233) 233
physiology (232) 232
dosage and administration (230) 230
aliskiren (228) 228
in-vitro (220) 220
analgesics (218) 218
glucagon-like peptide-1 (218) 218
drug therapy (217) 217
inflammation (215) 215
science (215) 215
lidocaine (214) 214
7-36 amide (212) 212
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6695) 6695
German (89) 89
Russian (64) 64
Spanish (63) 63
Japanese (59) 59
French (48) 48
Chinese (46) 46
Italian (22) 22
Portuguese (12) 12
Romanian (11) 11
Czech (3) 3
Danish (3) 3
Turkish (3) 3
Dutch (2) 2
Hungarian (2) 2
Polish (2) 2
Swedish (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Bone & Joint Surgery, ISSN 0021-9355, 02/2013, Volume 95, Issue 4, pp. 291 - 296
BACKGROUND:Appropriate pain management affects outcome after hip fracture surgery. Although multimodal pain management is commonly used for pain control for... 
KNEE | SURGERY | DEMENTIA | TOTAL JOINT ARTHROPLASTY | DELIRIUM | HOSPITAL STAY | LOCAL INFILTRATION ANALGESIA | ELDERLY PATIENTS | ORTHOPEDICS | PUMP | CONSUMPTION | POSTOPERATIVE PAIN | Fentanyl - administration & dosage | Single-Blind Method | Hip Fractures - surgery | Pyrazoles - therapeutic use | Prospective Studies | Fentanyl - therapeutic use | Humans | Male | Adrenergic alpha-Agonists - therapeutic use | Arthroplasty, Replacement, Hip - methods | Adrenergic alpha-Agonists - administration & dosage | Epinephrine - therapeutic use | Cyclooxygenase 2 Inhibitors - therapeutic use | Statistics, Nonparametric | Aged, 80 and over | Anesthetics, Local - therapeutic use | Anesthetics, Local - administration & dosage | Oxycodone - therapeutic use | Oxycodone - administration & dosage | Cyclooxygenase 2 Inhibitors - administration & dosage | Pain Management - methods | Analgesics, Opioid - therapeutic use | Anti-Bacterial Agents - administration & dosage | Morphine - administration & dosage | Sulfonamides - administration & dosage | Ketorolac - therapeutic use | Pain, Postoperative - drug therapy | Epinephrine - administration & dosage | Patient Satisfaction | Anti-Bacterial Agents - therapeutic use | Cefmetazole - therapeutic use | Female | Drug Therapy, Combination | Analgesia, Patient-Controlled | Treatment Outcome | Amides - therapeutic use | Celecoxib | Chi-Square Distribution | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Analgesics, Opioid - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Injections, Intra-Articular | Aged | Ketorolac - administration & dosage | Pain Measurement | Amides - administration & dosage | Morphine - therapeutic use | Cefmetazole - administration & dosage
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying, and... 
MEDICINE, GENERAL & INTERNAL | IN-VITRO | METFORMIN-TREATED PATIENTS | HEALTHY-SUBJECTS | 2ND-PHASE INSULIN-SECRETION | IMPROVES GLYCEMIC CONTROL | BETA-CELL APOPTOSIS | IV INHIBITOR | 7-36 AMIDE | IMPROVED GLUCOSE-TOLERANCE | EXENATIDE SYNTHETIC EXENDIN-4 | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 11/2017, Volume 109, pp. 533 - 540
Journal Article
Journal of Arthroplasty, The, ISSN 0883-5403, 2012, Volume 27, Issue 9, pp. 1731 - 1736.e1
Abstracts We investigated the safety and efficacy of the bilateral periarticular multimodal drug injection (PMDI) at a reduced dosage in patients undergoing... 
Orthopedics | pain management | periarticular multimodal drug injection | simultaneous bilateral total knee arthroplasty | Simultaneous bilateral total knee arthroplasty | Pain management | Periarticular multimodal drug injection | INTERVAL | SURGERY | INFILTRATION ANALGESIA | EFFICACY | PROTOCOL | BUPIVACAINE | HIP | TRIAL | ROPIVACAINE | ORTHOPEDICS | Fentanyl - administration & dosage | Prospective Studies | Humans | Epinephrine - administration & dosage | Male | Anesthesia, Spinal | Case-Control Studies | Incidence | Statistics, Nonparametric | Arthroplasty, Replacement, Knee | Female | Cefuroxime - administration & dosage | Anesthetics, Local - administration & dosage | Drug Therapy, Combination | Oxycodone - administration & dosage | Cyclooxygenase 2 Inhibitors - administration & dosage | Pain Management - methods | Ketoprofen - administration & dosage | Bupivacaine - administration & dosage | Treatment Outcome | Postoperative Complications - epidemiology | Celecoxib | Pyrazoles - administration & dosage | Injections, Intra-Articular - adverse effects | Analgesics, Opioid - administration & dosage | Aged | Pain Measurement | Amides - administration & dosage | Anti-Bacterial Agents - administration & dosage | Morphine - administration & dosage | Sulfonamides - administration & dosage | Care and treatment | Pain | Index Medicus
Journal Article
Journal Article
Journal Article